Telotristat and Somatostatin Analogue in Advanced Neuroendocrine Tumors - 102139

Spotlight
Video

Telotristat and Somatostatin Analogue in Advanced Neuroendocrine Tumors

NCCN2017 has 35 videos Subscribe Here

Loading........
Description: Matthew H. Kulke, MD, MMSc of Dana-Farber and Harvard Medical School explains whether or not somatostatin analogues were needed to see efficacy in treatment for carcinoid syndromes. This was recorded at the 2017 National Comprehensive Cancer Network (NCCN) Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ in Orlando, Florida.
Shared By : NCCN2017
Posted on : 03/31/17
Added : 1 year ago
Category : Other